FAST NEWS: Mega Genomics Priced at Low End, Though IPO Oversubscribed 8.6x
The latest: Shares of genetic testing company Mega Genomics Ltd. (6667.HK) will be priced at HK$18 each – the lower end of its IPO price range – with the company hoping to…
Mega Genomics Eyes Hong Kong IPO To Ride Growing Popularity of Genetic Testing
The genetic testing company is looking to raise up to $33 million in a Hong Kong IPO as its services become popular in China Key Takeaways: Mega Genomics is looking…
RELATED ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
A blockbuster cancer drug? TYK’s claims go under the microscope
2410.HK
- Smithfield piques IPO investor appetite with turnaround story, low valuation
